Stroke Trial, Recruiting NCT06127602 Sponsor: University of Illinois at Chicago Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06127602
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 90 years of age
  • People who have weakness on one side of the body following a stroke
  • People whose stroke occurred more than 6 months ago
  • People who are able to walk on a treadmill for at least 2 minutes, with or without an ankle-foot brace
  • People who can understand and communicate in English
  • People who score above 25 out of 30 on a standard memory and thinking test (Mini-Mental State Examination)
  • People who have not used any electrical stimulation device on their leg muscles during walking (such as Bioness or Walkaide) in the past 6 weeks

Who may not be able to join:

  • People whose heart rate, blood pressure, or blood oxygen levels fall outside safe ranges at the time of baseline testing (confirm with trial site for specific thresholds)
  • People who weigh more than 250 pounds
  • People with significant muscle stiffness or spasticity in the affected limb, as measured by a standard clinical scale (Ashworth scale score above 2)
  • People who have lost feeling in the affected leg to a degree where they cannot sense light touch or the electrical stimulation used in the study
  • People with severe bone density loss (confirm with trial site for specific measurement threshold)
  • People with cognitive impairment, indicated by a score below 25 on the Mini-Mental State Examination
  • People with severe communication difficulties affecting both understanding and expression of language, as measured by a standard screening test (confirm with trial site for specific threshold)
  • People whose affected leg has a higher level of motor function, as measured by the Chedoke McMaster Leg Assessment Scale (score above 4) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tanvi Bhatt, University of Illinois at Chicago

Phone: 312-413-9772

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Falls; Change in Reactive Stability; Change in Proactive Stability; Change in Vertical Limb support; Change in Muscle synergies; Change in Perturbation-evoked potentials; Change in time-frequency power

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov